Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters.
Division of Pediatric Allergy-Immunology, Department of Pediatrics, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver, Colorado, USA.
Donald Y M
DY
Leung
Richard A
RA
Nicklas
James T
JT
Li
I Leonard
IL
Bernstein
Joann
J
Blessing-Moore
Mark
M
Boguniewicz
Jean A
JA
Chapman
David A
DA
Khan
David
D
Lang
Rufus E
RE
Lee
Jay M
JM
Portnoy
Diane E
DE
Schuller
Sheldon L
SL
Spector
Stephen A
SA
Tilles
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000279:Administration, Cutaneous; D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000465:Algorithms; D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D065095:Calcineurin Inhibitors; D019090:Case Management; D002648:Child; D002675:Child, Preschool; D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D017453:Dermatitis, Irritant / Q000150:complications / Q000628:therapy; D004643:Emollients / Q000008:administration & dosage / Q000627:therapeutic use; D005512:Food Hypersensitivity / Q000150:complications / Q000178:diet therapy; D006801:Humans; D007223:Infant; D010789:Phototherapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy / Q000209:etiology
D000276:Adjuvants, Immunologic; D000305:Adrenal Cortex Hormones; D018926:Anti-Allergic Agents; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D065095:Calcineurin Inhibitors; D004643:Emollients